Summary
As attorneys prepare for the start of the second Vioxx trial Monday in Atlantic City, N.J., both sides say the outcome from the first trial signals vast changes ahead for the drug industry.
Merck & Co. Inc., the Whitehouse Station, N.J., maker of Vioxx, so far faces 4,951 lawsuits in connection with its arthritis painkiller, which the company pulled from the market nearly a year ago.See the full content of this document
Extract
Vioxx Trials to Pain Industry
The first trial resulted in a $253 million award to the plaintiff, and lawyers this week predicted that the Food and Drug Administration, whi...
See the full content of this document
Sponsored links
